XML 11 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2022 $ 99,885   $ 154,891 $ (55,006)
Beginning Balance (in shares) at Dec. 31, 2022   28,179,423    
Equity financing, net of issuance costs, Shares   12,386,478    
Equity financing, net of issuance costs 22,562   22,562  
Issuance of common stock warrants 0      
Stock-based compensation 3,115   3,115  
Issuance of common stock upon exercise of stock options 76   76  
Issuance of common stock upon exercise of stock options, shares   51,774    
Issuance of common stock under employee stock purchase plan 138   138  
Issuance of common stock under employee stock purchase plan, Shares   82,034    
Vesting of restricted stock units, Shares   28,071    
Net Income (Loss) (26,124)     (26,124)
Ending Balance at Sep. 30, 2023 99,652   180,782 (81,130)
Ending Balance (in shares) at Sep. 30, 2023   40,727,780    
Beginning Balance at Jun. 30, 2023 86,208   157,185 (70,977)
Beginning Balance (in shares) at Jun. 30, 2023   28,341,302    
Equity financing, net of issuance costs, Shares   12,386,478    
Equity financing, net of issuance costs 22,562   22,562  
Stock-based compensation 1,035   1,035  
Net Income (Loss) (10,153)     (10,153)
Ending Balance at Sep. 30, 2023 99,652   180,782 (81,130)
Ending Balance (in shares) at Sep. 30, 2023   40,727,780    
Beginning Balance at Dec. 31, 2023 $ 90,036   181,822 (91,786)
Beginning Balance (in shares) at Dec. 31, 2023 40,793,848 40,793,848    
Equity financing, net of issuance costs, Shares   12,385,883    
Equity financing, net of issuance costs $ 15,141 $ 1 15,140  
Issuance of common stock warrants 132   132  
Stock-based compensation 2,900   2,900  
Issuance of common stock upon exercise of stock options 4   4  
Issuance of common stock upon exercise of stock options, shares   1,779    
Issuance of common stock under employee stock purchase plan 81   81  
Issuance of common stock under employee stock purchase plan, Shares   54,314    
Vesting of restricted stock units, Shares   67,169    
Net Income (Loss) (21,026)     (21,026)
Ending Balance at Sep. 30, 2024 $ 87,268 $ 1 200,079 (112,812)
Ending Balance (in shares) at Sep. 30, 2024 53,302,993 53,302,993    
Beginning Balance at Jun. 30, 2024 $ 78,928   184,175 (105,247)
Beginning Balance (in shares) at Jun. 30, 2024   40,915,331    
Equity financing, net of issuance costs, Shares   12,385,883    
Equity financing, net of issuance costs 15,141 $ 1 15,140  
Stock-based compensation 760   760  
Issuance of common stock upon exercise of stock options 4   4  
Issuance of common stock upon exercise of stock options, shares   1,779    
Net Income (Loss) (7,565)     (7,565)
Ending Balance at Sep. 30, 2024 $ 87,268 $ 1 $ 200,079 $ (112,812)
Ending Balance (in shares) at Sep. 30, 2024 53,302,993 53,302,993